65-46-3
Chemical Structure
Cytidine
Synonym(s): Cytosine β-D-riboside; Cytosine-1-β-D-ribofuranoside
- No. CAS: 65-46-3
- Formula:C9H13N3O5
- Molecular Weight:243.22
IUPAC Name: 4-amino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
InChIKey: UHDGCWIWMRVCDJ-XVFCMESISA-N
SMILES: O[C@H]1[C@@H](O)[C@H](N2C(N=C(N)C=C2)=O)O[C@@H]1CO
Biological Activity: Cytidine is a pyrimidine nucleoside and acts as a component of RNA. Cytidine is a precursor of uridine. Cytidine controls neuronal-glial glutamate cycling, affecting cerebral phospholipid metabolism, catecholamine synthesis, and mitochondrial function[1][2][3].
| Referencia número | Nombre del producto | Pureza | Descripciòn | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Cytidine | 99.97% | Cytidine is a pyrimidine nucleoside and acts as a component of RNA. Cytidine is a precursor of uridine. Cytidine controls neuronal-glial glutamate cycling, affecting cerebral phospholipid metabolism, catecholamine synthesis, and mitochondrial function. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Cytidine (Standard) | 99.97% | Cytidine (Standard) is the analytical standard of Cytidine. This product is intended for research and analytical applications. Cytidine is a pyrimidine nucleoside and acts as a component of RNA. Cytidine is a precursor of uridine. Cytidine controls neuronal-glial glutamate cycling, affecting cerebral phospholipid metabolism, catecholamine synthesis, and mitochondrial function. In Vivo:Cytidine decreases glutamate/glutamine levels and induces earlier improvement of depressive symptoms. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Cytidine-d13 | Cytidine-d13 (Cytosine β-D-riboside-d13) is deuterium labeled Cytidine (HY-B0158). Cytidine is a pyrimidine nucleoside and acts as a component of RNA. Cytidine is a precursor of uridine. Cytidine controls neuronal-glial glutamate cycling, affecting cerebral phospholipid metabolism, catecholamine synthesis, and mitochondrial function. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Cytidine-1',2',3',4',5'-13C5 | Cytidine-1',2',3',4',5'-13C5 is the 13C-labeled Cytidine (HY-B0158). Cytidine is a pyrimidine nucleoside and acts as a component of RNA. Cytidine is a precursor of uridine. Cytidine controls neuronal-glial glutamate cycling, affecting cerebral phospholipid metabolism, catecholamine synthesis, and mitochondrial function. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Cytidine-13C | 99.0% | Cytidine-13C is the 13C labeled Cytidine. Cytidine is a pyrimidine nucleoside and acts as a component of RNA. Cytidine is a precursor of uridine. Cytidine controls neuronal-glial glutamate cycling, affecting cerebral phospholipid metabolism, catecholamine | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Cytidine-13C9 | 98.69% | Cytidine-13C9 (Cytosine β-D-riboside-13C9) is 13C labeled Cytidine (HY-B0158). Cytidine is a pyrimidine nucleoside and acts as a component of RNA. Cytidine is a precursor of uridine. Cytidine controls neuronal-glial glutamate cycling, affecting cerebral phospholipid metabolism, catecholamine synthesis, and mitochondrial function. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Cytidine-13C-1 | Cytidine-13C-1 is the 13C labeled Cytidine. Cytidine is a pyrimidine nucleoside and acts as a component of RNA. Cytidine is a precursor of uridine. Cytidine controls neuronal-glial glutamate cycling, affecting cerebral phospholipid metabolism, catecholami | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Cytidine-15N3 | 99.3% | Cytidine-15N3 is the 15N labeled Cytidine. Cytidine is a pyrimidine nucleoside and acts as a component of RNA. Cytidine is a precursor of uridine. Cytidine controls neuronal-glial glutamate cycling, affecting cerebral phospholipid metabolism, catecholamine synthesis, and mitochondrial function. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Cytidine-d2-1 | Cytidine-d2-1 is the deuterium labeled Cytidine. Cytidine is a pyrimidine nucleoside and acts as a component of RNA. Cytidine is a precursor of uridine. Cytidine controls neuronal-glial glutamate cycling, affecting cerebral phospholipid metabolism, catech | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Cytidine-13C9,15N3 | 98.9% | Cytidine-13C9,15N3 is the 13C and 15N labeled Cytidine. Cytidine is a pyrimidine nucleoside and acts as a component of RNA. Cytidine is a precursor of uridine. Cytidine controls neuronal-glial glutamate cycling, affecting cerebral phospholipid metabolism, catecholamine synthesis, and mitochondrial function. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Cytidine-d2 | 98.4% | Cytidine-d2 is the deuterium labeled Cytidine. Cytidine is a pyrimidine nucleoside and acts as a component of RNA. Cytidine is a precursor of uridine. Cytidine controls neuronal-glial glutamate cycling, affecting cerebral phospholipid metabolism, catecholamine synthesis, and mitochondrial function. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Cytidine-d | Cytidine-d is the deuterium labeled Cytidine. Cytidine is a pyrimidine nucleoside and acts as a component of RNA. Cytidine is a precursor of uridine. Cytidine controls neuronal-glial glutamate cycling, affecting cerebral phospholipid metabolism, catechol | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
5-Methylcytidine | 99.89% | 5-Methylcytidine is a nucleoside compound. 5-Methylcytidine has antiviral activity, and its IC50 against HSV-1 is 0.06 μM. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Xylocytidine | Xylocytidine is a cytidine analog. Cytidine analogs have a mechanism of inhibiting DNA methyltransferases (such as Zebularine, HY-13420), and have potential anti-metabolic and anti-tumor activities. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Cytarabine | 99.98% | Cytarabine, a nucleoside analog, causes S phase cell cycle arrest and inhibits DNA polymerase. Cytarabine inhibits DNA synthesis with an IC50 of 16 nM. Cytarabine has antiviral effects against HSV. Cytarabine shows anti-orthopoxvirus activity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Cytarabine hydrochloride (Standard) | ≥98% | Cytarabine (hydrochloride) (Standard) is the analytical standard of Cytarabine (hydrochloride). This product is intended for research and analytical applications. Cytarabine hydrochloride, a nucleoside analog, causes S phase cell cycle arrest and inhibits DNA polymerase. Cytarabine inhibits DNA synthesis with an IC50 of 16 nM. Cytarabine hydrochloride has antiviral effects against HSV. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Cytarabine-d2 | 98.0% | Cytarabine-d2 is the deuterium labeled Cytarabine. Cytarabine, a nucleoside analog, causes S phase cell cycle arrest and inhibits DNA polymerase. Cytarabine inhibits DNA synthesis with an IC50 of 16 nM. Cytarabine has antiviral effects against HSV. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Cytidine | 99.98% | L-Cytidine is the L-configurational form of Cytidine (HY-B0158). L-Cytidine is a pyrimidine nucleoside and a component of RNA. Cytidine regulates glial glutamate cycling, affects cephalin metabolism, catecholamine synthesis and mitochondrial function. L-Cytidine interacts with HSA, which may alter the structure and function of HSA. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
1-(β-D-Xylofuranosyl)-5-methylcytosine | 1-(β-D-Xylofuranosyl)-5-methylcytosine is a cytidine analog. Cytidine analogs have a mechanism of inhibiting DNA methyltransferases (such as Zebularine, HY-13420), and have potential anti-metabolic and anti-tumor activities. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
5'-Homocytidine | 5'- Homocytidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Uridine-d2-1 | 98.47% | Uridine-d2-1 is the deuterium labeled Uridine. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
5-Iodo-cytidine | 99.89% | 5-Iodo-cytidine (5-Iodo-D-cytidine) is a purine nucleoside analog that acts as an intermediate in organic synthesis. 5-Iodo-cytidine serves as a chemically modified nucleotide to replace partial cytidine residues in in vitro transcription, enhancing the translation efficiency and stability of chemically modified mRNA. Purine nucleoside analogs exhibit broad anti-tumor activity and target indolent lymphoid malignancies. 5-Iodo-cytidine can be used in mRNA therapy and tumor-related research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
5-Bromocytidine | 5-Bromocytidine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
5-Fluorocytidine | 99.88% | 5-Fluorocytidine is a member of cytidines, inhibits maturation of the 45S ribosomal RNA precursor. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
α-Cytidine | 98.68% | α-Cytidine is a nucleoside. Under appropriate prebiotic conditions, α-Cytidine can be generated from ribose 5'-phosphate, cyanamide and cyanoacetylene. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
5-Chloro-1-(β-D-arabinofuranosyl)cytidine | 5-Chloro-1-(β-D-arabinofuranosyl)cytidine is a kind of biochemical reagent. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Jonas DA, et al. Safety considerations of DNA in food. Ann Nutr Metab. 2001;45(6):235-54. [Content Brief]
- [2]. Wurtman RJ, et al. Effect of oral CDP-choline on plasma choline and uridine levels in humans. Biochem Pharmacol. 2000 Oct 1;60(7):989-92. [Content Brief]
- [3]. Machado-Vieira R, et, al. New therapeutic targets for mood disorders. ScientificWorldJournal. 2010 Apr 13;10:713-26. [Content Brief]